A multi-centre, open, investigator initiated phase IV clinical trial to evaluate the efficacy and safety of ingenol mebutate gel, 0.015% on the face and scalp, and 0.05% on the trunk and extremities, in Korean patients with actinic keratosis (PERFECT)
by Wiley Publishing.
Authors: Y. C. Kim, J. Y. Yang, J. S. Yoon, S. J. Jo, H. H. Ahn, K.-H. Song, D.-Y. Lee, K.-Y. Chung, Y.-H. Won, I.-H. Ki
Journal Article published
20/1/2018
in British Journal of Dermatology
volume
issue
on pages .
رتبه و نظرات
برای ارسال نظر، لطفا وارد شوید.
نظر دهید
Adding comments has been disabled.
نظرات (0)
هنوز نظری داده نشده است. شما اولین باشید!
